<DOC>
	<DOCNO>NCT01804452</DOCNO>
	<brief_summary>The purpose study evaluate several different test , include brain imaging , eye movement test , body fluid sample , measurement memory think ability , measure functional independence hope information use guide diagnosis treatment PSP CBD future . Recent advance understand biological cause disease offer hope new treatment . As treatment develop , sensitive specific biological measurement ( biomarkers ) need provide precise direct measure state brain , improve statistical power clinical trial . Brain imaging Magnetic Resonance Imaging ( MRI ) previously use measure disease-related change brain . The goal study identify best method analysis ( include eye movement , imaging , behavioral measure ) track PSP CBD time . In addition , certain biomarkers blood cerebrospinal fluid might also useful follow disease time . This study examine value blood CSF biomarkers relative brain imaging functional measure .</brief_summary>
	<brief_title>4 Repeat Tauopathy Neuroimaging Initiative</brief_title>
	<detailed_description />
	<mesh_term>Supranuclear Palsy , Progressive</mesh_term>
	<criteria>Clinical diagnosis Progressive Supranuclear Palsy Corticobasal Degeneration Must reliable study partner frequent contact subject Willing able undergo test procedure Significant neurological disease PSP CBD Presence pacemaker , aneurysm clip , artificial heart valve , ear implant , metal fragment foreign object eye , skin body</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Progressive Supranuclear Palsy</keyword>
	<keyword>Corticobasal Degeneration</keyword>
	<keyword>Biomarker</keyword>
	<keyword>Neuroimaging</keyword>
	<keyword>MRI</keyword>
	<keyword>Tau</keyword>
	<keyword>Oculomotor</keyword>
</DOC>